Julie Lamb, Senior Editor

About the Author Julie Lamb, Senior Editor

Julie joined Smarter Analyst across the world- all the way from Louisville, Kentucky- where she graduated with a Bachelor of Arts in English with a focus on creative writing from the University of Louisville.

Omeros Corporation (OMER): Analyst Believes HSCT-TMA Drug Poised to Become Primary Value Driver

H.C. Wainwright’s Ram Selvaraju is confident on OMER’s Phase 2 results hinting at “substantial” survival benefit for OMS721 in HSCT-TMA.

A Bull Pounds the Table on Apple Inc. (AAPL), A Bear Lifts Price Target on Tesla Inc (TSLA) Stock

One analyst anticipates AAPL’s “Other Product” revenues are on route to doubling; another analyst believes TSLA can achieve its long-awaited Model 3 production goal.

How Much Does Shopify Inc (US) (SHOP) Need to Spend to Grow Net Adds? Ross MacMillan Asks Key Questions

Though SHOP delivered a strong 4Q earnings show, RBC Capital’s Ross MacMillan still spots downside, even as he boosts his price target on the stock.

Square Inc (SQ) Draws Price Target Jump from Deutsche Bank Ahead of 4Q Showcase

Deutsche Bank’s Bryan Keane sings the praises of SQ’s “massive market opportunity” ahead.

What Is The Next Step for QUALCOMM, Inc. (QCOM) to Buy AVGO? Top Analyst Weighs In

RBC Capital’s Amit Daryanani continues to be bullish on QCOM amid the “saga” of M&A talks with AVGO.

Apricus Biosciences Inc (APRI) Loses a Bull After ED Cream Gets Hit with Problematic CRL

H.C. Wainwright’s Ram Selvaraju now sees 4% downside for APRI stock, disappointed and surprised by the FDA’s CRL for Vitaros.

Mulesoft Inc (MULE) Stock Set to Become a Rewarding Investment: Top Analyst

Following a second robust quarterly beat in a row for MULE, Canaccord’s Richard Davis now angles for 8% upside potential for shares.

Helios and Matheson Analytics Inc (HMNY) Taking an Even Bigger Shot at the Movie Theater Market

Helios and Matheson Analytics Inc (NASDAQ:HMNY) is gunning for the movie theater market, as its …